SYRA VS BIOL Stock Comparison

Performance

SYRA
10/100

SYRA returned -63.43% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

BIOL
10/100

BIOL returned -99.32% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Volatility

SYRA
33/100

SYRA has had a lower than average amount of volatility over the last 12 months giving it a score of 33 of 100.

BIOL
54/100

BIOL has had a higher than average amount of volatility over the last 12 months giving it a score of 54 of 100.

Analyst Price Targets

SYRA

"Analyst Price Targets" not found for SYRA

BIOL
88/100

2 analysts offer 12-month price targets for BIOL. Together, they have an average target of 0, the most optimistic target put BIOL at 0 within 12-months and the most pessimistic has BIOL at 0.

Technicals

SYRA

"Technicals" not found for SYRA

BIOL
14/100

BIOL receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.

Earnings

SYRA

"Earnings" not found for SYRA

BIOL
10/100

BIOL has missed earnings 12 times in the last 20 quarters.

Profit

SYRA

"Profit" not found for SYRA

BIOL
10/100

Out of the last 20 quarters, BIOL has had 1 profitable quarters and has increased their profits year over year on 1 of them.

All score calculations are broken down here to help you make more informed investing decisions

Syra Health Corp. Class A Common Stock Summary

Nasdaq / SYRA

Healthcare

Medical - Care Facilities

Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.

Biolase, Inc. Summary

Nasdaq / BIOL

Healthcare

Medical - Devices

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, such as cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, pain therapy, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces, and teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

Power up your portfolio